Continuous Glucose Monitors Overestimate Glycemic Responses
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, March 6, 2025 -- Continuous glucose monitoring (CGM) can overestimate glycemic responses, according to a study published online Feb. 26 in The American Journal of Clinical Nutrition.
Katie M. Hutchins, from the University of Bath in the United Kingdom, and colleagues examined glycemic responses to different test foods/beverages using CGM versus capillary sampling among 15 healthy female and male participants (nine and six, respectively). Participants completed seven laboratory visits in a randomized crossover design with washout of ≥48 hours between visits. At each visit, participants consumed an oral carbohydrate challenge composed of either 50 g glucose or equivalent carbohydrate as a whole-fruit, blended-fruit, or commercial fruit smoothie.
The researchers found that compared with capillary estimates, CGM-estimated fasting and postprandial glucose concentrations were 0.9±0.6 and 0.9±0.5 mmol/L higher, respectively. There was variation in CGM bias by postprandial test, with the glycemic index for commercial fruit smoothie higher with CGM than capillary (69 versus 53). There was variation by participant in the differences in CGM versus capillary fasting glucose concentrations. Time >7.8 mmol/L was overestimated by about fourfold with CGM in unadjusted analyses; this overestimate was reduced to about twofold after adjustment for baseline differences.
"These data demonstrate that a CGM can overestimate postprandial glycemia, and to differing degrees across foods/beverages," the authors write. "Therefore, if accurate quantification of postprandial glycemia is the primary aim, then capillary blood should be the preferred method and CGM may not be suitable, at least with respect to the CGM device tested in the present study."
Several authors disclosed ties to the pharmaceutical, nutrition, and other industries; the data were supported by an unrestricted grant from Innocent Drinks.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-07 12:00
Read more

- Few Nonsurgical Treatments Show Effectiveness for Low Back Pain
- Kennedy Orders Takedown of Fake CDC Vaccine Web Page
- FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
- Glucose Monitors Improve Traffic Safety For Diabetic Drivers
- Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
- FDA Approves Tremfya for Active Crohn Disease in Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions